Luciferase Expression Allows Bioluminescence Imaging But Imposes Limitations on the Orthotopic Mouse (4T1) Model of Breast Cancer.
about
Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade.Tracking Tumor Colonization in Xenograft Mouse Models Using Accelerator Mass Spectrometry
P2860
Luciferase Expression Allows Bioluminescence Imaging But Imposes Limitations on the Orthotopic Mouse (4T1) Model of Breast Cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Luciferase Expression Allows B ...... (4T1) Model of Breast Cancer.
@en
type
label
Luciferase Expression Allows B ...... (4T1) Model of Breast Cancer.
@en
prefLabel
Luciferase Expression Allows B ...... (4T1) Model of Breast Cancer.
@en
P2093
P2860
P1433
P1476
Luciferase Expression Allows B ...... (4T1) Model of Breast Cancer.
@en
P2093
A A Latanova
A Kilpeläinen
E S Starodubova
F G Zabozlaev
G M Yusubalieva
M A Abakumov
M G Isaguliants
N F Grinenko
T O Abakumova
P2860
P2888
P356
10.1038/S41598-017-07851-Z
P407
P577
2017-08-10T00:00:00Z
P6179
1091144103